Bears may hold key to osteoporosis treatment

April 6, 2011 By Marcia Goodrich
Seth Donahue's work on bear parathyroid hormone could lead to a new treatment for osteoporosis.

All it takes is a few days of bed rest for human bones to start to weaken. Stretch that out many weeks, and we risk full-blown osteoporosis and its attendant woes of broken hips, wrists and vertebrae. Bears hibernate for months on end. Yet, when they wake up in spring, their bones are just as strong as before they settled down for their long winter’s nap.

Seth Donahue, an associate professor of biomedical engineering at Michigan Technological University, has been studying bear physiology for years, teasing out the mechanism that protects them from osteoporosis. Just as in humans, bear bones release minerals during periods of inactivity, like hibernation. But instead of excreting calcium, reabsorb it and put it back where it belongs—in their skeleton.

One big reason bears have such healthy bones is because of the actions of parathyroid hormone, Donahue surmises. Human parathyroid hormone, while it plays a key role in bone health, may not be as efficient as the bear variety when it comes to shuttling minerals back into bones.

A critical step in testing that hypothesis was to get a supply of bear parathyroid hormone, so Donahue and his research team made their own. Using samples of American black bear blood provided by another research study, they isolated the DNA responsible for making bear parathyroid hormone. Then they cloned the gene and used E. coli bacteria to turn out gobs of the stuff. No bears were involved in the making of this hormone, he is quick to point out. “We don’t use bears for this research,” Donahue says.

With a $1 million grant from the National Institutes of Health, Donahue and his team are undertaking two experiments using their bear hormone that they hope will lead to a new, more effective treatment for human osteoporosis.

They are growing human bone-making cells in the lab, which they will treat with either human or bear parathyroid hormone and then measure differences in the two groups. “Preliminary studies have shown that the bear parathyroid hormone is better at preventing cell death,” Donahue says. It also appears to have a robust effect on the signaling pathways that control bone formation in humans.

A second study begins this summer to see if bear parathyroid hormone has potential for treating osteoporosis in post-menopausal women, the time when they are most vulnerable to the bone-thinning condition. Expanding on an earlier study, Donahue and his team will give human and bear hormones to mice that have had their ovaries surgically removed and developed osteoporosis. Then they will gauge the hormones’ effect on the bone density of the mice.

What’s next? Donahue chairs the scientific advisory board for the pharmaceutical company Aursos, which recently filed an application with the Food and Drug Administration to use the recombinant bear as a treatment for . “It would be years away, but if the studies go well, it could be used in humans,” Donahue says.

Explore further: New research reveals important role for parathyroid glands and their control of calcium

Related Stories

Pa. bear hunt may set record

November 18, 2005

Pennsylvania Game Commission officials said this year's black bear season, which opens Monday, is likely to produce some exceptionally large bears.

Vitamin D linked to reduced mortality rate in CKD

May 7, 2008

For patients with moderate to severe chronic kidney disease (CKD), treatment with activated vitamin D may reduce the risk of death by approximately one-fourth, suggests a study in the August Journal of the American Society ...

Timing is everything in combination therapy for osteoporosis

November 4, 2010

The adult human skeleton undergoes constant remodeling, with new bone forming at sites that have been broken down by a precise process called resorption. During remodeling, skeletal stem cells are recruited to resorption ...

Recommended for you

These shrews have heads that shrink with the season

October 23, 2017

If any part of the body would seem ill equipped to shrink, it would probably be the head and skull. And, yet, researchers reporting in Current Biology on October 23 have found that the skulls of red-toothed shrews do shrink ...

Single-molecule dissection of developmental gene control

October 23, 2017

Scientists at EPFL and Max Plank have made significant discoveries on how developmental genes are controlled by the methyltransferase enzyme PRC2. The study is published in Nature Structural & Molecular Biology.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.